Pfizer has begun testing the supply of the Covid-19 vaccine in four U.S. states Coronavirus

Pfizer has launched a pilot delivery program for four U.S. experimental Covid-19 vaccines to help pharmaceutical manufacturers meet delivery challenges due to its ultra-cold storage requirements.

U.S. pharmaceutical manufacturers said they chose Rhode Island, Texas, New Mexico and Tennessee for the project because of the overall size differences, population diversity and immunization infrastructure, as well as the settings the state needs to reach people in different urban and rural areas.

“The four states covered by this pilot program will not receive the same dose of vaccine as other states because of this pilot, and they will not receive any separate consideration,” Pfizer said in a statement.

“We are hopeful that the results obtained from this vaccine delivery pilot will serve as a model for other states and international governments in the United States, as they prepare to implement an effective Covid-19 vaccine program.”

One week ago, Pfizer released preliminary data on its vaccine, developed with German partner Bionatech SE, showing it to be more than 90% effective.

Significantly lower than the quality of vaccines at two to eight degrees Celsius (3-4-46 degrees Fahrenheit), Pfeiffer’s vaccine must be sent and stored at -70 degrees Celsius (-94 ° F)

Earlier Monday, rival Modarna Inc. said its experimental vaccine was effective in preventing Covid-19 based on interim data from a late-stage trial, hoping the vaccine against the disease could be ready for use soon. Modern vaccines do not require ultracooled refrigeration, which may prove to be a greater advantage than Pfizer products.

Both Pfizer and Modarna use a new technology called synthetic messenger RNA to activate the immune system against the waxy virus.

READ  Important US Twitter accounts hacked in Bitcoin rip-off

Experts have expressed concern about the distribution challenges associated with the Pfizer vaccine due to the need for specialized storage.

The Dow Jones Industrial Average rose to a record high for the first time in nine months, surpassing the current of optimism that a vaccine could soon control the coronavirus and its economic devastation.

The pioneering path is the stock of companies that will benefit the economy the most as a result of compulsory interventions such as airlines, movie theaters and banks.

Pandemic-winning stocks enjoyed from lockdown orders like Amazon and Zoom Video Communications lagged behind because they are no longer the only safe bets they can play.

The Dow jumped 470.63 points, or 1.6%, to 29,950.44. This surpassed the previous record of 29,551.42 set in February before the plague of panic-stricken stocks.

Including Reuters and AP

You May Also Like

About the Author: Forrest Morton

Organizer. Zombie aficionado. Wannabe reader. Passionate writer. Twitter lover. Music scholar. Web expert.

Leave a Reply

Your email address will not be published. Required fields are marked *